Life Insurance Corporation of India (LIC) has announced three new plans for sale from October 19, 2026. New Jeevan Dhara-II targets retirement income, while Health Shield and New Cancer Cover offer fixed-benefit protection against specified health risks.
Life Insurance Corporation of India (LIC) will make three new insurance plans available from October 19, 2026, expanding its offerings across retirement planning, health insurance and cancer protection. The products include a deferred annuity plan and two individual health insurance plans designed to provide financial benefits for specified medical conditions.
LIC announced the products on October 13 through a regulatory disclosure. The three plans are New Jeevan Dhara-II (Plan 892), Health Shield (Plan 907) and New Cancer Cover (Plan 908). Customers can purchase them through LIC’s website and authorised insurance distribution channels.
Three new LIC insurance plans explained
The three products address different financial protection needs.
- New Jeevan Dhara-II: Retirement income
New Jeevan Dhara-II is a non-participating, non-linked individual savings plan that provides deferred annuity income. Policyholders can select single-premium or regular-premium payments and choose between single-life and joint-life annuity options.
The plan offers guaranteed annuity rates at policy inception, subject to its terms. It aims to help customers plan a future income stream after a chosen deferment period.
- Health Shield: Health insurance benefits
LIC’s Health Shield is an individual health insurance plan that offers fixed benefits for specified medical events. Its features include daily hospital cash benefits, lump-sum payments for major surgeries and critical illnesses, and a no-claim benefit that can increase health cover.
The plan also offers optional riders for additional premiums, subject to eligibility and policy conditions. Customers should review the benefit limits, exclusions and waiting periods before buying the policy.
- New Cancer Cover: Protection against specified cancers
New Cancer Cover provides fixed financial benefits following the diagnosis of specified early-stage or major-stage cancers. The plan links payouts to the applicable sum assured rather than reimbursing actual treatment expenses.
It also provides a monthly income benefit following a major-stage cancer diagnosis, along with a premium-waiver benefit under specified conditions. The policy terms determine eligible diagnoses, payout amounts and other benefits.
When can customers buy the plans?
LIC will offer all three products from October 19, 2026. Customers can access them through licensed agents, corporate agents, brokers, insurance marketing firms and the insurer’s official website.
The plans fall under the non-participating and non-linked categories, meaning they do not participate in LIC’s profits through bonuses and do not link benefits to market performance. However, their individual benefit structures differ.
What should buyers check?
Customers should compare each product with their financial needs before purchasing. Those considering Health Shield or New Cancer Cover should check coverage limits, eligibility, exclusions, waiting periods and claim conditions. They should also understand that fixed-benefit health insurance may not cover every hospital bill.
For New Jeevan Dhara-II, buyers should assess the annuity options, premium commitments and timing of future payouts.
LIC’s new products expand its insurance portfolio, but customers should read the official sales brochures and policy documents carefully before making a decision.
Life Insurance Overview: Understand the basics of life insurance and why adequate protection matters for individuals and families.
Also Read: India Launches Two Credit Risk Insurance Policies for Shipbuilders
Disclaimer: This MyRupia article provides information based on publicly available government, regulatory and industry sources. It does not constitute investment, financial, tax, insurance or legal advice. Information, examples, market data and expert views may change over time and do not represent a recommendation to buy, sell, invest in or surrender any financial product. Readers should consider their individual circumstances and consult a qualified financial professional before making financial decisions.
